StevenseJohnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, such as the ocular surface, oral cavity, and genitals. In patients with extensive skin detachment and a poor prognosis, the condition is called toxic epidermal necrolysis (TEN). Severe ocular complications (SOCs) appear in somedbut not alldSJS/TEN patients who are diagnosed by dermatologists, and cold medicines including multi-ingredient cold medications and nonsteroidal anti-inflammatory drugs are the main causative drugs particularly for SJS/TEN with SOCs and all SJS and TEN. In this review, we focus on the genetic predisposition of cold medicine-related SJS/TEN (CM-SJS/TEN) with SOCs. CM-SJS/ TEN with SOCs was strongly associated with HLA-A*02:06 and significantly associated with HLA-B*44:03 in Japanese individuals, significantly associated with HLA-B*44:03 in Indian and Brazilian individuals, and associated with HLA-A*02:06 in Korean individuals. In the first genome-wide association study (GWAS), we found an association between the prostaglandin E receptor 3 (PTGER3) gene and SJS/ TEN with SOCs. In this study, we focused on CM-SJS/TEN with SOCs and found that the association of CM-SJS/TEN with SOCs became stronger than all SJS/TEN with SOCs. In the second GWAS, we found an association between the IKZF1 gene and CM-SJS/TEN with SOCs not only in Japanese, but also in Korean and Indian populations. Moreover, we found that TSHZ2 gene single nucleotide polymorphisms (SNPs) also showed especially low p values in the Japanese population; however, this association was not found in the Korean population. Furthermore, we investigated the interaction between susceptibility genes, and found multiplicative interactions of HLA-A*02:06 and TLR3 SNPs and additive interactions of HLA-A*02:06 and PTGER3 SNPs.
StevenseJohnson syndrome/toxic epidermal necrolysis in ophthalmology
StevenseJohnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, such as the ocular surface, oral cavity, and genitals. In patients with extensive skin detachment and a poor prognosis, the condition is called toxic epidermal necrolysis (TEN). Table 1 shows the diagnostic criteria for SJS and TEN in Japan. 1 A definite diagnosis of SJS requires mucosal lesions, whereas a definite diagnosis of TEN does not. Thus, SJS/TEN with mucosal lesions consists of SJS and a part of TEN. Moreover, not all cases of SJS/TEN with mucosal lesions have severe ocular lesions such as severe conjunctivitis with pseudomembrane and ocular surface epithelial defects in the acute stage ( Figure 1 ). Figure 2 shows a case of severe conjunctivitis with pseudomembrane and ocular surface epithelial defects in the acute stage. It is reported that about 40% of SJS/TEN cases had severe ocular complications (SOCs) with pseudomembrane and ocular surface epithelial defects. 1 Furthermore, dermatologists see SJS/TEN patients only in their acute stage, whereas ophthalmologists encounter such patients not only in the acute stage but also in the chronic stage. Therefore, for ophthalmologists, it is not easy to render a differential diagnosis of SJS or TEN when patients present in the chronic stage because the vesiculobullous skin lesions expressed in the acute stage have healed by the chronic stage. 2 Diagnosis of SJS/TEN in Conflicts of interest: The author has no conflicts of interest to declare.
ophthalmology was based on a confirmed history of acute-onset high fever, serious mucocutaneous illness with skin eruptions, and involvement of at least two mucosal sites including the ocular surface. 3e14 SJS/TEN patients with SOC in the acute stage often experience severe ocular sequelae, such as vision loss and very severe dry eye for which these patients would not have been able to lead a normal life. 15 Figure 3 shows severe ocular sequelae such as very severe dry eye, trichiasis, symbrepharon, scarring of lid conjunctiva, and conjunctival invasion of the cornea in the chronic stage. We defined patients with SOCs in the acute stage as those who manifested pseudomembranes and epithelial defects on the ocular surface (cornea and/or conjunctiva), 16 and in the chronic stage as patients with ocular sequelae such as severe dry eye, trichiasis, symblepharon, and conjunctival invasion into the cornea. 15 Thus, ophthalmologists tend to report both SJS and TEN with SOCs as "SJS" in a broad sense. 2 To summarize, SOCs appear in somedbut not alldSJS/TEN patients who are diagnosed by dermatologists.
Causative drug and human leukocyte antigen analysis
SJS/TENs are rare with an annual incidence rate of 1e6 cases/1 million persons, 1, 17, 18 but SJS/TEN carry high mortality rates of 3%
for SJS and 27% for TEN. 19 Moreover, they often associated with inciting drugs. 3e5, 10,18,20e22 It was reported that allopurinol and anticonvulsants such as carbamazepine are the main inciting drugs for SJS/TEN 23 ; however, we 2e5,10 and others 20, 22 found that cold medicines including multi-ingredient cold medications and nonsteroidal anti-inflammatory drugs (NSAIDs) are also major causative drugs for SJS/TEN. Furthermore, the association between human leukocyte antigen (HLA) genotypes and drug-induced severe cutaneous adverse reactions (SCARs) including SJS/TEN has been reported. Carbamazepine-induced SJS/TEN exhibited a very strong association with the HLA-B*15:
Taiwanese Han Chinese patients. 24 The HLA-A*31:01 allele was also reported to be strongly associated with carbamazepine-induced SCAR including SJS/TEN and drug-induced hypersensitivity syndrome (DIHS) in Japanese [case n ¼ 77, control (tolerant) n ¼ 420, OR ¼ 9.5, p ¼ 1. 
We have likewise reported that cold medicines including multiingredient cold medications and NSAIDs were the main causative drugs for SJS/TEN with SOCs in all SJS and TEN.
1e3,5,10,31 About 80% of our SJS/TEN with SOC patients have developed SJS/TEN within several days after receiving treatment for common cold.
2,10
Interestingly, allopurinol might induce SJS/TEN without SOCs, 30 and not all cases of carbamazepine-induced SJS/TEN have SOCs. 2 In summary, genetic predisposition, such as HLA genotype, might be different depending on the causative drugs and their phenotype, for example, with and without SOCs ( Figure 4 ). 
Genome wide association study

PTGER3: first genome-wide association study
We previously reported that a genome-wide association study (GWAS) using the Affymetrix GeneChip Mapping 500K Array Set (Affymetrix, Santa Clara, Calif) showed an association between prostaglandin E receptor 3 (PTGER3) gene and SJS/TEN with SOCs. 10 Moreover, we analyzed a total of 38 single nucleotide polymorphisms (SNPs) of the PTGER3 gene using DigiTag2 assay 32, 33 and found 20 SNPs associated with SJS/TEN with SOCs ( Figure 5 ). 34 The protein of PTGER3 gene is EP3. EP3 is one of the four receptors (EP1, EP2, EP3 and EP4) of prostaglandin E 2 (PGE2). 35 Cold medicine such as NSAIDs (e.g., ibuprofen and loxoprofen) and cold medicine ingredients (e.g., acetaminophen) have the suppressive effect in the production of prostanoid, including PGE ( Figure 6 ). 35 It was reported that PGE 2 acts at EP3 in the airway epithelium and negatively regulates inflammation in the mouse asthma model. 36 We also reported that EP3 negatively regulated the inflammation of ocular surface in the mouse allergy conjunctivitis model 37 and skin in the mouse contact dermatitis model. 38 Because PGE 2 acts at EP3 and negatively regulates mucocutaneous inflammation, 36e38 we suggest that the suppression of PGE 2 production by cold medicine might contribute to the onset and pathogenesis of CM-SJS/TEN with SOCs. 2,10 Therefore, we turned to CM-SJS/TEN with SOCs. When we focused on CM-SJS/ TEN with SOCs, the association with PTGER3 gene became stronger than that in total SJS/TEN with SOCs; seven of 18 SNPs already reported to be associated with SJS/TEN were significantly associated with CM-SJS/TEN with SOCs after Bonferroni correction. 14 PTGER3 SNP rs1327464 (G vs. A) was most significantly associated with CM-SJS/TEN with SOCs; the OR for the major allele was 0.232 (p ¼ 7.92 Â 10 À10 ). 14 Figure 7 shows the p values of the 18 SNPs in the dominant models; PTGER3 SNP rs1327464 (GG vs. GA þ AA); p ¼ 1.90 Â 10 À8 , OR ¼ 0.223. 14 We also previously reported that EP3 protein levels are much lower in the conjunctival epithelium of patients with SJS/TEN with SOCs than control individuals such as conjunctival chalasis patients and chemical burn patients (Figure 8) . 39 Thus, EP3 expression might be downregulated in the ocular surface of the SJS/TEN with SOCs patients. Furthermore, because patients with CM-SJS/TEN with SOCs have developed this condition by taking cold medicines after having a common cold as a result of some viral or mycoplasma infections, we assume that not only cold medicine, but also some microbial infectious such as virus or mycoplasma, might be important and necessary to trigger the onset of SJS/TEN with SOCs.
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IKZF1: second GWAS
In the second GWAS, we focused on CM-SJS/TEN with SOCs, and performed a GWAS of Japanese 117 cases and 691 controls using the Affymetrix AXIOM Genome-Wide ASI 1 Array (Affymetrix, Santa Clara, Calif). 5 The Manhattan plot of the GWAS indicated that the HLA-A region showed the strongest association with susceptibility to CM-SJS/TEN with SOCs ( Figure 9 ), 5 which was consistent with findings from our previous studies. 3, 11, 12 Outside of the HLA region, there were 60 SNPs with p < 10 À3 (in the allele frequency, dominant model, or recessive model) in the GWAS. 5 Of the 60 SNPs, 47 were p < 10 À4 , and 11 of these 47 were p < 10 À5 . 5 Among the 11 SNPs of eight genes that were p < 10 À5 , . 5 These findings show that IKZF1 may be a universal marker for susceptibility to CM-SJS/TEN with SOCs. 5 Furthermore, we have performed a functional analysis for SNPs of the IKZF1 gene and found that the Ik2/Ik1 (both are splicing isoforms) ratio may be influenced by IKZF1 SNPs that are significantly associated with susceptibility to CM-SJS/TEN with SOCs. 5 To elucidate the role of IKZF1 in the pathogenesis of CM-SJS/TEN with SOCs, we are going to do further investigations.
TSHZ2: second GWAS
Among the 11 SNPs of eight genes that were p < 10 À5 in the second GWAS, TSHZ2 also showed especially low p values
. 5 Furthermore, we have examined a total of 17 SNPs of the near region of TSHZ2 gene using 101 CM-SJS/TEN cases and 200 control samples, and found that seven SNPs (rs4811338, rs1555278, rs2092954, rs4371408, rs6021911, rs4809905, and rs6096940) showed a significant genome-wide association with CM-SJS/TEN with SOCs (Table 2 ). However, these SNPs were not associated with CM-SJS/TEN with SOCs in the Korean population (data not shown). TSHZ2 might be a susceptibility gene for CM-SJS/TEN with SOCs in the Japanese population.
Interaction between susceptibility genes
HLA-A*02:06 and TLR3
SNPs have been widely used as genetic markers for identifying human disease susceptibility genes for the past decade. Moreover, it has recently become apparent that geneegene interactions are meaningful in addition to major single-locus effects. 34 We previously reported that, in addition, HLA-A*02:06, 3,11,12 PTGER3, 10,34 and IKZF1, 5 TLR3 9,34 SNPs showed significant associations with SJS/TEN with SOCs, although the expression of TLR3 protein on the ocular surface was not different between SJS/TEN and controls such as conjunctival chalasis and chemical burn ( Figure 10 ). 34 When we focused on CM-SJS/TEN with SOCs, five of the seven SNPs, which were significantly associated with SJS/TEN with SOCs in our previous report, 13, 34 were still associated with CM-SJS/TEN with SOCs (Table 3) . We previously also reported that HLA-A*02:06 with TLR3 SNPs exerted more than additive effects in SJS/TEN with SOCs. 13 (Table 4) . By interaction analysis, HLA-A*02:06 and TLR3 SNP rs3775296T/ T, which were in strong LD with TLR3 SNP rs5743312T/T, manifested more than additive effects; therefore, the multiplicative interactions of HLA-A and TLR3 gene might be required for the onset of CM-SJS/TEN with SOCs. HLA-A is a component of HLA Class I, which resides on the surface of all nucleated cells and alerts the immune system that the cell may be infected by a virus, thereby targeting the cell for destruction, and TLR3 recognizes viral double-stranded RNA. 40 As the onset of SJS/TEN was associated not only with the administration of drugs but also with putative microbial infection, multiplicative interactions of HLA-A and TLR3 gene might contribute to the characteristic and pathogenic immune response to the microbial infection.
HLA-A*02:06 and PTGER3
Next, we looked for interactive effects between these seven SNPs of the PTGER3 gene and HLA-A*02:06 in CM-SJS/TEN with SOCs, because the PTGER3 SNPs were significantly associated with the patients. 14 We found an interaction with additive effects between HLA-A*02:06 and the high-risk genotypes PTGER3 rs1327464 GA or AA (OR ¼ 10.8, p ¼ 2.56 Â 10
À7
; Table 5 ). 14 Thus, the interaction between HLA-A*02:06 and PTGER3 SNP might strongly contribute to the onset of CM-SJS/TEN with SOCs.
Application strategy in future
Because CM-SJS/TEN is a rare condition that probably has a complex genetic background, it is reasonable to posit multiplicative interactions of genes such as HLA-A and TLR3, 13 and HLA-A and
PTGER3.
14 Notably, after removing samples with both HLA-A*02:06 and TLR3 SNP rs3775296 T/T, the additive effect between HLA-A*02:06 and PTGER3 rs1327464 GA/AA persisted in CM-SJS/TEN with SOCs, suggesting that the interactions are independent of each other. 14 These findings might show that the combinations of the two CM-SJS/TEN with SOCs associated polymorphisms, such as HLA-A*02:06 and TLR3 SNP and HLA-A*02:06 and PTGER3 SNP, could give improvements for a genetic testing compared with using only one susceptibility gene. 14 Based on all of our previous observations, we suggest that in addition to microbial infections and cold medicines, the combination of multiple gene polymorphisms and their interactions contribute strongly to the onset of CM-SJS/TEN with SOCs. 14 
Table 6
Interaction between HLA-A*02:06 and PTGER3 rs1327464 GA/AA among Korean individuals. 
